Functional impact of SNPs in OATP1B1 on rosuvastatin uptake in Xenopus oocytes

被引：0
|
作者：
Brown, CD
Gray, PA
Wang, Y
Windass, AS
机构：
[1] Univ Newcastle Upon Tyne, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Astra Pharmaceut, DMPK, Wilmington, DE 19850 USA
来源：
FASEB JOURNAL | 2005年 / 19卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1608 / A1608
页数：1
相关论文
共 50 条
  • [41] Effect of OATP1B1 genotypes on plasma concentrations of endogenous OATP1B1 substrates and drugs, and their association in healthy volunteers
    Mori, Daiki
    Kashihara, Yushi
    Yoshikado, Takashi
    Kimura, Miyuki
    Hirota, Takeshi
    Matsuki, Shunji
    Maeda, Kazuya
    Irie, Shin
    Ieiri, Ichiro
    Sugiyama, Yuichi
    Kusuhara, Hiroyuki
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : 78 - 86
  • [42] Effect of OATP1B1 genetic polymorphism on the uptake of tamoxifen and its metabolite, endoxifen
    Ga, Chun-Mei
    Pu, Zhichen
    He, Chunyuan
    Liang, Dahu
    Jia, Yuanwei
    Yuan, Xiaolong
    Wang, Guangji
    Xie, Haitang
    ONCOLOGY REPORTS, 2017, 38 (02) : 1124 - 1132
  • [43] Structure of human drug transporters OATP1B1 and OATP1B3
    Anca-Denise Ciută
    Kamil Nosol
    Julia Kowal
    Somnath Mukherjee
    Ana S. Ramírez
    Bruno Stieger
    Anthony A. Kossiakoff
    Kaspar P. Locher
    Nature Communications, 14
  • [44] Structure of human drug transporters OATP1B1 and OATP1B3
    Ciuta, Anca-Denise
    Nosol, Kamil
    Kowal, Julia
    Mukherjee, Somnath
    Ramirez, Ana S.
    Stieger, Bruno
    Kossiakoff, Anthony A.
    Locher, Kaspar P.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [45] Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1
    Nakagomi-Hagihara, R.
    Nakai, D.
    Tokui, T.
    Abe, T.
    Ikeda, T.
    XENOBIOTICA, 2007, 37 (05) : 474 - 486
  • [46] PREDICTION OF HEPATIC UPTAKE TRANSPORTER (OATP1B1) DRUG-DRUG INTERACTIONS
    Hinton, Laura K.
    Thomas, Jennifer S.
    Kenworthy, Kathryn E.
    Galetin, Aleksandra
    Houston, J. Brian
    DRUG METABOLISM REVIEWS, 2007, 39 : 320 - 320
  • [47] The pharmacogenetics of OATP1B1 variants and their impact on the pharmacokinetics and efficacy of elbasvir/grazoprevir
    Guo, Zifang
    Caro, Luzelena
    Robertson, Michael N.
    Hwang, Peggy
    Hoover, Patricia
    Wudarski, Christen
    Maiuri, Kristina
    Wang, Ying-Hong
    Mogg, Robin
    Mehrotra, Devan, V
    Blanchard, Rebecca
    Shaw, Peter M.
    PHARMACOGENOMICS, 2019, 20 (09) : 631 - 641
  • [48] Kinetic Characterization of Fluorescein Uptake In Human Cryopreserved Hepatocytes and in OATP1B1 and OATP1B3 Transfected CHO Cells
    De Bruyn, Tom
    Fattah, Sarinj
    Stieger, Bruno
    Augustijns, Patrick
    Annaert, Pieter
    DRUG METABOLISM REVIEWS, 2010, 42 : 291 - 292
  • [49] INFLUENCE OF OATP1B1, OATP1B3 AND ABCC2 ON THE HEPATIC UPTAKE OF PRIMOVIST® IN HEALTHY VOLUNTEERS.
    Kuehn, J.
    Nassif, A.
    Oswald, S.
    Modess, C.
    Weitschies, W.
    Hosten, N.
    Siegmund, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S9 - S9
  • [50] Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1*15 and OATP1B3
    van de Steeg, E.
    Venhorst, J.
    Jansen, H. T.
    Nooijen, I. H. G.
    DeGroot, J.
    Wortelboer, H. M.
    Vlaming, M. L. H.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 70 : 29 - 36
12345